233
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Design, Synthesis, Biological Evaluation of New Porphyrin and Metalloporphyrin Derivatives

, , , & ORCID Icon
Pages 6697-6715 | Received 12 Nov 2021, Accepted 05 Sep 2022, Published online: 21 Sep 2022

References

  • C. P. Tidwell, P. Bharara, G. Rudeseal, T. Rudeseal, F. H. Rudeseal, C. A. Simmer, D. McMillan, K. Lanier, D. Fondren, L. L. Folmar, et al, “Synthesis and Characterization of 5, 10, 15, 20-Tetra [3-(3-Trifluoromethyl) Phenoxy],” Molecules 12, no. 7 (2007): 1389–98.
  • C. Spangler, “Fluorimetric and Mass-spectrometric Methods for Analysis of GTP-converting Signal-transducing Proteins and Enzymes” (Doctoral dissertation, 2010). Thesis of the University of Regensburg (PhD); Chemistry and Pharmacy > Institut für Analytische Chemie, Chemo- und Biosensorik
  • K. I. Ozoemena, “Anodic Oxidation and Amperometric Sensing of Hydrazine at a Glassy Carbon Electrode Modified with Cobalt (II) Phthalocyanine–Cobalt (II) Tetraphenylporphyrin (CoPc-(CoTPP) 4) Supramolecular Complex,” Sensors 6, no. 8 (2006): 874–91.
  • O. Ikeda, K. Yoshinaga, and J. Lei, “Nitric Oxide Detection with Glassy Carbon Electrodes Coated with Charge-Different Polymer Films,” Sensors 5, no. 4 (2005): 161–70.
  • J. Yu, X. Wang, B. Zhang, Y. Weng, and L. Zhang, “Prolonged Excited-State Lifetime of Porphyrin Due to the Addition of Colloidal SiO2 to Triton X-100 Micelles,” Langmuir 20, no. 5 (2004): 1582–6.
  • E. De Clercq, “The Role of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) in the Therapy of HIV-1 Infection,” Antiviral Research 38, no. 3 (1998): 153–79.
  • E. De Clercq and G. Li, “Approved Antiviral Drugs over the past 50 Years,” Clinical Microbiology Reviews 29, no. 3 (2016): 695–747.
  • K. J. Barnham, C. L. Masters, and A. I. Bush, “Neurodegenerative Diseases and Oxidative Stress,” Nature Reviews. Drug Discovery 3, no. 3 (2004): 205–14.
  • M. S. Cooke, M. D. Evans, M. Dizdaroglu, and J. Lunec, “Oxidative DNA Damage: mechanisms, Mutation, and Disease,” FASEB Journal 17, no. 10 (2003): 1195–214. b) T. Finkel and N. J. Holbrook. “Oxidants, Oxidative Stress and the Biology of Ageing,” Nature; 408, no. 6809 (2000), 239–47.‏
  • C. Frochot and S. Mordon, “Update of the Situation of Clinical Photodynamic Therapy in Europe in the 2003–2018 Period,” Journal of Porphyrins and Phthalocyanines 23, no. 04n05 (2019), 347–357.
  • Y. J. Cai, L. P. Ma, L. F. Hou, B. Zhou, L. Yang, and Z. L. Liu, “Antioxidant Effects of Green Tea Polyphenols on Free Radical Initiated Peroxidation of Rat Liver Microsomes,” Chemistry and Physics of Lipids 120, no. 1–2 (2002): 109–17.
  • A. N. Vzorov, D. W. Dixon, J. S. Trommel, L. G. Marzilli, and R. W. Compans, “Inactivation of Human Immunodeficiency Virus Type 1 by Porphyrins,” Antimicrobial Agents and Chemotherapy 46, no. 12 (2002): 3917–25.
  • K. A. Zhdanova, I. O. Savelyeva, A. V. Ezhov, A. P. Zhdanov, K. Y. Zhizhin, A. F. Mironov, N. A. Bragina, A. A. Babayants, I. S. Frolova, N. I. Filippova, et al, “Cationic Meso-Arylporphyrins and Their Antiviral Activity against HSV-1,” Pharmaceuticals 14, no. 3 (2021): 242.
  • D. Sengupta, U. Timilsina, Z. H. Mazumder, A. Mukherjee, D. Ghimire, M. Markandey, K. Upadhyaya, D. Sharma, N. Mishra, T. Jha, et al, “Dual Activity of Amphiphilic Zn (II) Nitroporphyrin Derivatives as HIV-1 Entry Inhibitors and in Cancer Photodynamic Therapy,” European Journal of Medicinal Chemistry 174 (2019): 66–75.
  • N. M. Moura, M. Esteves, C. Vieira, G. M. Rocha, M. A. Faustino, A. Almeida, J. A. Cavaleiro, C. Lodeiro, and M. G. Neves, “Novel β-Functionalized Mono-Charged Porphyrinic Derivatives: Synthesis and Photoinactivation of Escherichia coli,” Dyes and Pigments 160 (2019): 361–71.
  • E. Ruggiero, and S. N. Richter, “G-Quadruplexes and G-Quadruplex Ligands: targets and Tools in Antiviral Therapy,” Nucleic Acids Research 46, no. 7 (2018): 3270–83.
  • M. S. Rodríguez-Morgade, M. Planells, T. Torres, P. Ballester, and E. Palomares, “A Colorimetric Molecular Probe for Cu (ii) Ions Based on the Redox Properties of Ru (ii) Phthalocyanines,” Journal of Materials Chemistry. 18, no. 2 (2008): 176–81.
  • A. A. Fadda, E. El-Gendy, H. M. Refat, and E. H. Tawfik, “Utility of Dipyrromethane in the Synthesis of Some New A2B2 Porphyrin and Their Related Porphyrin like Derivatives with Their Evaluation as Antimicrobial and Antioxidant Agents,” Dyes and Pigments 191 (2021): 109008.
  • D. Holten, D. F. Bocian, and J. S. Lindsey, “Probing Electronic Communication in Covalently Linked Multiporphyrin Arrays. A Guide to the Rational Design of Molecular Photonic Devices,” Accounts of Chemical Research 35, no. 1 (2002): 57–69.
  • P. Rothemund, and A. R. Menotti, “Porphyrin Studies. IV. The Synthesis of α, β, γ, δ-Tetraphenylporphine,” Journal of the American Chemical Society 63, no. 1 (1941): 267–70.
  • A. D. Adler, F. R. Longo, and W. Shergalis, “Mechanistic Investigations of Porphyrin Syntheses. I. Preliminary Studies on ms-Tetraphenylporphin,” Journal of the American Chemical Society 86, no. 15 (1964): 3145–9.
  • X. Huang, and J. T. Groves, “Oxygen Activation and Radical Transformations in Heme Proteins and Metalloporphyrins,” Chemical Reviews 118, no. 5 (2018): 2491–553.
  • P. M. R. Pereira, “Galactose-Conjugated Photosensitizers for Targeted Cancer Photodynamic Therapy” (Doctoral dissertation, Universidade de Aveiro (Portugal), 2018).‏
  • W. Zhang, W. Lai, and R. Cao, “Energy-Related Small Molecule Activation Reactions: oxygen Reduction and Hydrogen and Oxygen Evolution Reactions Catalyzed by Porphyrin-and Corrole-Based Systems,” Chemical Reviews 117, no. 4 (2017): 3717–97.
  • Y. Ding, W.-H. Zhu, and Y. Xie, “Development of Ion Chemosensors Based on Porphyrin Analogues,” Chemical Reviews 117, no. 4 (2017): 2203–56.
  • A. J. Harte, and T. Gunnlaugsson, “Synthesis of α-Chloroamides in Water,” Tetrahedron Letters. 47, no. 35 (2006): 6321–4.
  • J. Micky, N. Saleh, S. Mohamed, S. Mohameda, and M. Salem, “Reaction and Antimicrobial Activity of 1-Arylethylene Benzofuranyl Ketone Derivatives,” CSIR 37, no. 40 (2006). doi:10.1002/chin.200640166
  • C. A. Duckworth, “ Stable Emulsion Flowable Formulation of a 2-Chloroacetamide Herbicide and an Imidazolinone Herbicide” (U.S. Patent No. 5,538,938, Washington, DC: U.S. Patent and Trademark Office, 1996).
  • T. Ikeuchi, T. Ohkawa, S. Ohno, Y. Yamaji, and Y. Ogawa, “Phytotoxicity Controlling Agent for Upland Farming and Phytotoxicity Controlling Method” (U.S. Patent No. 8,318,635. Washington, DC: U.S. Patent and Trademark Office, 2012.)
  • F. Zaragoza, and H. Stephensen, “Solid-Phase Synthesis of Substituted 4-Acyl-1, 2, 3, 4-Tetrahydroquinoxalin-2-Ones,” The Journal of Organic Chemistry 64, no. 7 (1999): 2555–7.
  • G. Sirasani, and R. B. Andrade, “Sequential One-Pot Cyclizations: Concise Access to the ABCE Tetracyclic Framework of Strychnos Alkaloids,” Organic Letters 11, no. 10 (2009): 2085–8.
  • T. Kaoudi, L. D. Miranda, and S. Z. Zard, “An Easy Entry into Berbane and Alloyohimbane Alkaloids via a 6-Exo Radical Cyclization,” Organic Letters 3, no. 20 (2001): 3125–7.
  • M. J. Evans, and B. F. Cravatt, “Mechanism-Based Profiling of Enzyme Families,” Chemical Reviews 106, no. 8 (2006): 3279–301.
  • M. Shaul, G. Abourbeh, O. Jacobson, Y. Rozen, D. Laky, A. Levitzki, and E. Mishani, “Novel Iodine-124 Labeled EGFR Inhibitors as Potential PET Agents for Molecular Imaging in Cancer,” Bioorganic & Medicinal Chemistry 12, no. 13 (2004): 3421–9.
  • H. Tang, Z. Dong, Z. Merican, D. Margetić, Ž. Marinić, M. J. Gunter, R. N. Warrener, D. Officer, D. N. Butler, and R. N. Warrener, “Hinged Bis-Porphyrin Scaffolds I. The Synthesis of a New Porphyrin Diene and Its Role in Constructing Hinged Porphyrin Dyads and Cavity Systems,” Tetrahedron Letters. 50, no. 6 (2009): 667–70.
  • S. Rai, and M. Ravikanth, “Synthesis of Covalently Linked Unsymmetrical Porphyrin Pentads Containing Three Different Porphyrin Subunits,” The Journal of Organic Chemistry 73, no. 21 (2008): 8364–75.
  • C.-S. Chan, AK-S. Tse, and K. S. Chan, “Highly Versatile Methods for the Synthesis of Quinonylporphyrins via Benzannulation of Fischer Carbene Complexes and Palladium-Catalyzed Cross-Coupling Reactions,” The Journal of Organic Chemistry 59, no. 20 (1994): 6084–9.
  • A. A. Fadda, R. E. El‐Mekawy, A. I. El‐Shafei, and H.Freeman, “Synthesis and Pharmacological Screening of Novel Meso‐Substituted Porphyrin Analogs,” Archiv Der Pharmazie 346, no. 1 (2013): 53–61.
  • M. Amaravathi, M. M. Babu, and G. Chandramouli, “Synthesis of Meso-Tetrakis (2-Chloroquinolin-3-yl) Porphyrins,” Arkivoc 2007, no. 1 (2007): 148–53.
  • A. Amer, W. I. El-Eraky, and S. Mahgoub, “Synthesis, Characterization and Antimicrobial Activity of Some Novel Quinoline Derivatives Bearing Pyrazole and Pyridine Moieties,” Egyptian Journal of Chemistry 0, no. 0 (2018): 0.
  • A. S. Munde, A. N. Jagdale, S. M. Jadhav, and T. K. Chondhekar, “Synthesis and Characterization of Some Transition Metal Complexes of Unsymmetrical Tetradentate Schiff Base Ligand,” Journal of the Korean Chemical Society. 53, no. 4 (2009): 407–14.
  • S. J. Thompson, M. R. Brennan, S. Y. Lee, and G. Dong, “Synthesis and Applications of Rhodium Porphyrin Complexes,” Chemical Society Reviews 47, no. 3 (2018): 929–981.
  • Z. Bıyıklıoğlu, H. Kantekin, and M. Özil, “Microwave-Assisted Synthesis and Characterization of Novel Metal-Free and Metallophthalocyanines Containing Four 14-Membered Tetraaza Macrocycles,” Journal of Organometallic Chemistry 692, no. 12 (2007): 2436–40.
  • M. Brewis, G. J. Clarkson, P. Humberstone, S. Makhseed, and N. B. McKeown, “The Synthesis of Some Phthalocyanines and Napthalocyanines Derived from Sterically Hindered Phenols,” Chemistry - A European Journal 4, no. 9 (1998): 1633–40.
  • (a) E. Manoj, M. P. Kurup, and A. Punnoose, “Preparation, Magnetic and EPR Spectral Studies of Copper (II) Complexes of an Anticancer Drug Analogue,” Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy 72, no. 3 (2009): 474–483. (b) M. Nonoyama, “Five-Coordinate Nickel (II) and Copper (II) Complexes of Quinquedentate Acid Amides,” Inorganica Chimica Acta. 10 (1974): 59–63.
  • B. Singh, B. P. Yadava, and R. C. Aggarwal, “Synthesis & Characterization of 1-Phenyl-5-Benzoyl-4-Thiobiuret Complexes with Oxovanadium (IV), Cobalt (II & III), Nickel (II), Copper (II), Cadmium (II) & Mercury (II),” Indian Journal of Chemistry 23A (1984): 441–444.
  • D. Kivelson and R. Neiman, “ESR Studies on the Bonding in Copper Complexes,” Journal of Chemical Physics. 35, no. 1 (1961): 149–55.
  • I. Procter, B. Hathaway, and P. Nicholls, “The Electronic Properties and Stereochemistry of the Copper (II) Ion. Part I. Bis (Ethylenediamine) Copper (II) Complexes,” Journal of the Chemical Society A: Inorganic, Physical, Theoretical (1968): 1678–84.
  • B. Hathaway and D. Billing, “The Electronic Properties and Stereochemistry of Mono-Nuclear Complexes of the Copper (II) Ion,” Coordination Chemistry Reviews 5, no. 2 (1970): 143–207.
  • L. Zao-Ying, Z. Yue-Ning, X. Wei, Z. Xun-Jin, G. Zhen-Ting, and L. Yi, “Study on Synthesis and Biological Activities of Novel Water-Soluble Metalloporphyrins,” Wuhan University Journal of Natural Sciences 6, no. 4 (2001): 841–5.
  • B. J. Day, I. Batinic-Haberle, and J. D. Crapo, “Metalloporphyrins Are Potent Inhibitors of Lipid Peroxidation,” Free Radical Biology & Medicine 26, no. 5–6 (1999): 730–736.
  • F. I. Abdullaev, “Cancer Chemopreventive and Tumoricidal Properties of Saffron (Crocus Sativus L.),” Experimental Biology and Medicine 227, no. 1 (2002): 20–525.
  • G. A. Cordell, C. K. Angerhofer, and J. M. Pezzuto, “Recent Studies on Cytotoxic, anti-HIV and Antimalarial Agents from Plants,” Pure and Applied Chemistry 66, no. 10–11 (1994): 2283–2286.
  • J. Singh, K. B. Ashok, R. Rajapandi, T. Ghosh, A. Mondal, and B. Maiti, “Synthesis and Anticancer Activity of Some 1, 3, 4-Oxadiazole Derivatives against Ehlirch Ascites Carcinoma Bearing Mice Model,” Asian Journal of Chemistry 22, no. 5 (2010): 4099–103.
  • D. K. Dash, S. S. Nayak, S. Samanta, T. Ghosh, T. Jha, and B. C. Maiti, “Antitumor Activity and Antioxidant Role of Ichnocarpus Frutescens against Ehrlich Ascites Carcinoma in Swiss Albino Mice,” Natural Product Sciences. 13, no. 1 (2007): 54–60.
  • G. Bischoff and S. Hoffmann, “DNA-Binding of Drugs Used in Medicinal Therapies,” Current Medicinal Chemistry 9, no. 3 (2002): 321–48.
  • R. Martinez and L. Chacon-Garcia, “The Search of DNA-Intercalators as Antitumoral Drugs: what It Worked and What Did Not Work,” Current Medicinal Chemistry 12, no. 2 (2005): 127–51.
  • E. Abdel-Latif, M. M. Fahad, and M. A. Ismail, “Synthesis of N-Aryl 2-Chloroacetamides and Their Chemical Reactivity towards Various Types of Nucleophiles,” Synthetic Communications. 50, no. 3 (2020): 289–314.
  • A. A. Fadda, R. E. El-Mekawy, and A. I. El-Shafei, “Synthesis, Antiviral, Cytotoxicity and Antitumor Evaluations of A4 Type of Porphyrin Derivatives,” Journal of Porphyrins and Phthalocyanines 19, no. 06 (2015): 753–768.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.